Evidence map›Paper›PMID 33924456›Full record

ArticleAntibiotics (Basel, Switzerland)2021

The Bacterial Genomic Context of Highly Trimethoprim-Resistant DfrB Dihydrofolate Reductases Highlights an Emerging Threat to Public Health.

Claudèle Lemay-St-Denis, Sarah-Slim Diwan, Joelle N Pelletier

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A conserved SH3-like fold in diverse putative proteins tetramerizes into an oxidoreductase providing an antimicrobial resistance phenotype.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Claudèle Lemay-St-DenisDepartment of Biochemistry and Molecular Medecine, Université de Montréal, Montréal, QC H3T 1J4, Canada.ORCID 0000-0003-4865-0267
Sarah-Slim DiwanDepartment of Biochemistry and Molecular Medecine, Université de Montréal, Montréal, QC H3T 1J4, Canada.
Joelle N PelletierDepartment of Biochemistry and Molecular Medecine, Université de Montréal, Montréal, QC H3T 1J4, Canada.
Centre in Green Chemistry and Catalysis · CA

Funding

NSERC (National Sciences and Engineering Research Council of Canada) RGPIN-2018-04686
6 · The paper itself

Abstract

Type B dihydrofolate reductase (

Indexed as

antibiotic resistancegenomic contextmobile genetic elementsresistometype II dihydrofolate reductase

Identifiers

PMID33924456
PMCPMC8103504
OpenAlexW3156311624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.